Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
112.69
+0.59 (+0.53%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys?
February 09, 2024
There's room for multiple winners in the fast-growing weight-loss market.
Via
The Motley Fool
This Is What Whales Are Betting On Abbott Laboratories
February 08, 2024
Via
Benzinga
Abbott Laboratories Stock Getting Closer To Key Technical Benchmark
February 07, 2024
Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates
February 07, 2024
When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.
Via
InvestorPlace
Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever
February 07, 2024
Healthcare is an excellent place to find some tried and true wealth compounders.
Via
The Motley Fool
Healthcare And Life Science Funds And ETFs Performance 2023-2024
February 05, 2024
Healthcare stocks usually provide a defensive posture to a stock portfolio.
Via
Talk Markets
Topics
ETFs
Is Abbott Laboratories Stock a Buy Now?
February 03, 2024
Can Abbott Laboratories be a reliable income stock to hang on to now?
Via
The Motley Fool
Looking At Abbott Laboratories's Recent Unusual Options Activity
January 30, 2024
Via
Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
January 26, 2024
Via
Benzinga
2 Stocks to Buy Near Their 52-Week Highs
February 05, 2024
It's not too late to invest in these stocks.
Via
The Motley Fool
2 Healthcare Dividend Kings to Buy and Hold Forever
February 04, 2024
It's going to take a lot to interrupt these companies' streaks.
Via
The Motley Fool
Abbott Faces Lawsuit As Grandmother Questions PediaSure's Height Growth Claims
February 03, 2024
Abbott Laboratories faces a lawsuit questioning the efficacy of PediaSure Grow & Gain nutrition drinks in promoting height growth.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?
February 02, 2024
Abbott Labs is using its well-established strengths to make gains in the weight loss market.
Via
The Motley Fool
4 med tech stocks with improving prognosis for 2024
January 31, 2024
MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025.
Via
MarketBeat
Exposures
COVID-19
Cracking The Code: Understanding Analyst Reviews For Abbott Laboratories
January 25, 2024
Via
Benzinga
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
January 28, 2024
Aging is an inevitability, as much as we try to deny it. Under this context, these AgeTech stocks may prove quite relevant.
Via
InvestorPlace
Stock Market Continues To Rally; ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review
January 26, 2024
The S&P 500 and Dow Jones hit fresh record highs on Friday.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
World's Smallest Brain Stimulation Device For Movement Disorder: FDA Approved Abbott's Liberta RC DBS system
January 25, 2024
Abbott's Liberta RC DBS system, the world's smallest FDA-approved rechargeable deep brain stimulation device. With only 10 recharges a year, it's compatible with NeuroSphere Virtual Clinic, reducing...
Via
Benzinga
Exposures
Product Safety
Abbott Laboratories on track for new highs in 2024
January 25, 2024
Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact.
Via
MarketBeat
Exposures
COVID-19
Stock Market Extends Record Highs, S&P 500 Hits 4,900 On Tech Rally, Microsoft's $3 Trillion Mark: What's Driving Markets Wednesday?
January 24, 2024
It’s a bullish day on Wall Street, with major U.S. large-cap indices reaching record highs, driven by broad-based rallies in tech-related stocks as investors continue to embrace the AI trade.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript
January 24, 2024
ABT earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand
January 24, 2024
Abbott Laboratories exceeds expectations with Q4 sales of $10.24B, showcasing resilience despite softer demand for COVID-19 testing. CEO anticipates continued growth in 2024.
Via
Benzinga
Exposures
COVID-19
Abbott Labs Skids On Light Earnings Guidance Despite Quarterly Sales Beat
January 24, 2024
Abbott beat sales expectations and earnings came in light for the fourth quarter.
Via
Investor's Business Daily
Abbott Laboratories Barely Hits Q4 Target With $1.19 EPS
January 24, 2024
Abbott Laboratories announces Q4 results with $10.24 billion in revenue and an EPS of $1.19.
Via
Talk Markets
Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks
January 24, 2024
Earnings have served to mitigate early January's weakness, and sentiment appears to be upbeat going into Wednesday's session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Scheduled For January 24, 2024
January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion.
Via
Benzinga
Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High
January 24, 2024
The CNN Money Fear and Greed index showed a further increase in overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Netflix, Tesla And 3 Stocks To Watch Heading Into Wednesday
January 24, 2024
With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
January 23, 2024
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth.
Via
Benzinga
7 Safe-Haven Stocks to Protect Your Portfolio During a Recession
January 23, 2024
We may not be out of the woods yet, which means certain stable enterprises should be on your radar.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.